indazoles and xav939
indazoles has been researched along with xav939 in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Carlson, JH; De, P; Dey, N; Leyland-Jones, B; Marcus, A; Wu, H | 1 |
| Bitler, BG; Bradford, AP; Corr, BR; Moroney, MR; Qamar, L; Wolsky, R; Woodruff, E | 1 |
Other Studies
2 other study(ies) available for indazoles and xav939
| Article | Year |
|---|---|
Wnt-beta-catenin pathway signals metastasis-associated tumor cell phenotypes in triple negative breast cancers.
Topics: Adenomatous Polyposis Coli Protein; beta Catenin; Brain Neoplasms; Carcinoma; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dishevelled Proteins; Female; Fibronectins; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds, 3-Ring; Humans; Indazoles; Integrins; Matrix Metalloproteinase 7; Microscopy, Confocal; Microscopy, Fluorescence; Microscopy, Video; Mutation; Phenotype; RNA Interference; RNA, Small Interfering; Sulfonamides; Sulindac; Triple Negative Breast Neoplasms; Up-Regulation; Wnt Proteins; Wnt Signaling Pathway | 2016 |
Inhibiting Wnt/beta-catenin in CTNNB1-mutated endometrial cancer.
Topics: beta Catenin; Cell Line, Tumor; Cell Survival; Disease Management; Disease Susceptibility; Endometrial Neoplasms; Female; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds, 3-Ring; Humans; Imidazoles; Indazoles; Molecular Targeted Therapy; Mutation; Pyridines; Recurrence; Wnt Proteins; Wnt Signaling Pathway | 2021 |